Sciwind Biosciences secures Chinese approval for its GLP-1 agonist Xianyida, entering a crowded but high-stakes diabetes treatment market dominated by global giants, as the country grapples with the world's largest diabetic population.
PennyMac Financial Services capped a robust fiscal 2025 with Q4 net income of $107 million, overcoming headwinds from an unexpected wave of mortgage prepayments. While competitive pressures limited margin expansion, CEO David Spector pointed to strategic tech investments and a significant embedded refinance portfolio as catalysts for targeted mid-to-high teens ROE later this year.
As the STOXX Europe 600 grapples with volatility, some investors are turning their gaze to smaller, often overlooked companies. We examine three European penny stocks, each with a market capitalization exceeding €10 million, assessing their potential amidst a challenging macroeconomic backdrop.
Bank of America has raised its price target for clinical-stage biopharma firm Xencor (XNCR), highlighting a cautiously improving landscape for the sector driven by data catalysts, M&A, and capital access.
DXC Technology's latest earnings reveal a company in transition, betting big on 'AI-native' products to offset declines in its legacy IT services. While revenue dipped, improved bookings and a strong cash position signal cautious optimism for its strategic pivot.
Microsoft's commercial contracted backlog more than doubled year-over-year to $625 billion, fueled by AI demand. However, a closer look reveals customer concentration risks, slower near-term revenue conversion, and soaring capital expenditures that temper the bullish narrative.
Calix reports historic 2025 financial results, surpassing $1 billion in annual revenue, while outlining its strategic pivot to a third-generation 'Agent Workforce' platform and capitalizing on a projected multi-billion dollar BEAD program opportunity.
SpaceX is reportedly targeting June 2026 for its long-awaited public market debut, with sources suggesting the timing could be synchronized with a rare planetary alignment and CEO Elon Musk's 55th birthday, as the company seeks capital for its ambitious Mars missions.
Major U.S. federal investment to build a domestic rare earth supply chain emerges as a direct competitive threat to Lynas Rare Earths, coinciding with the planned retirement of its long-serving CEO Amanda Lacaze. The developments test the Australian miner's strategic position in a market defined by geopolitical tensions and supply security concerns.
In a move to rebalance bilateral trade, India has agreed to significant purchases of U.S. goods including petroleum, defense systems, and commercial aircraft under a newly announced agreement, a senior official confirmed.
Despite a recent share price dip and declining earnings per share, Harvey Norman Holdings (ASX:HVN) has generated a robust 82% total shareholder return since 2021, fueled by dividends and investor confidence in its long-term strategy.
Once a futuristic concept, asset tokenization is now a tangible reality. Major platforms are integrating tokenized versions of traditional assets like U.S. stocks, gold, and Treasury bonds, blurring the lines between crypto and conventional finance and enabling 24/7 trading.
South African insurer OUTsurance Group has rewarded long-term investors with a remarkable total shareholder return of 444% over the past five years, significantly outperforming its share price growth, driven by strong earnings and consistent dividends.
Salesforce lands a $5.6 billion Army modernization contract and launches a wildfire-fighting consortium with Lockheed Martin and others, as investors weigh long-term public sector growth against recent share price declines.
A nationwide class action lawsuit alleges Costco's Kirkland Signature Rotisserie Chicken is misleadingly marketed as having 'No Preservatives,' spotlighting growing scrutiny over clean-label claims in the grocery sector and potential risks to the retailer's reputation.
As major tech firms announce significant layoffs across Washington, the region grapples with a fundamental question: Is this a temporary downturn or a structural pivot toward AI and new industries? The impact ripples far beyond corporate campuses, threatening the vitality of local small businesses that built their models on tech's explosive growth.
Amidst a backdrop of stable rates and cautious optimism, a handful of low-priced Asian equities are drawing investor scrutiny for their resilience and strategic positioning. We analyze three such companies navigating property downturns, infrastructure demand, and consumer shifts.
Credo Technology Group is deepening its integration into hyperscale AI infrastructure through the launch of its high-bandwidth Blue Heron retimer and a strategic patent licensing agreement with 3M, positioning itself as a key enabler for next-generation AI clusters.
The AI and data management firm, Cordel Group Plc (LON:CRDL), is forecast to reach breakeven in 2027 after significant losses. With aggressive growth targets and a conservative balance sheet, analysts are watching closely to see if the company can navigate its critical investment phase.
As the AI infrastructure race intensifies, Nvidia appears poised for another year of robust growth, driven by system-level sales, a resilient margin profile, and a formidable software ecosystem that competitors struggle to match.
